FDA poised to outlaw breast reconstruction for breast cancer survivors using their own fat tissue

The U.S. Food and Drug Administration held public hearings for two days this week to allow for public commenting on proposed guidance relating to the regulation of human cells, tissues or tissue-based products. In its current form, this guidance will classify a woman’s own fat tissue as a drug when used in breast reconstruction procedures. [...]

2016-09-15T16:40:41+00:00September 15th, 2016|Bone Marrow Stem Cells, Breast Cancer, Cancer, FDA, News|

Modulation of Cytokines in Cancer Patients by Intravenous Ascorbate Therapy

Nina Mikirova, Neil Riordan, Joseph Casciari Med Sci Monit 2016; 22:14-25 DOI: 10.12659/MSM.895368 BACKGROUND: Cytokines play an important role in tumor angiogenesis and inflammation. There is evidence in the literature that high doses of ascorbate can reduce inflammatory cytokine levels in cancer patients. The objective of this study was to investigate the effect of treatment [...]

2016-02-15T17:06:37+00:00February 15th, 2016|Cancer, Neil Riordan, News, PhD|

Why Stem Cells Work: Clinical Trials for Spinal Cord Injury, Multiple Sclerosis, Rheumatoid Arthritis, and Duchenne’s Muscular Dystrophy

Neil Riordan, PhD speaks at the Riordan-McKenna Institute and Stem Cell Institute fall seminar in Southlake, Texas on October 10, 2015. Dr. Riordan discusses: How our lab selects uses specialized screening techniques to select only the stem cells that we know will be the most useful for our patients. Only about 1 in 100 cords [...]

The dual effect of MSCs on tumour growth and tumour angiogenesis

Michelle Kéramidas, Florence de Fraipont, Anastassia Karageorgis, Anaïck Moisan, Virginie Persoons, Marie-Jeanne Richard, Jean-Luc Coll and Claire Rome Abstract (provisional) Introduction Understanding the multiple biological functions played by human mesenchymal stem cells (hMSCs) as well as their development as therapeutics in regenerative medicine or in cancer treatment are major fields of research. Indeed, it has [...]

2013-04-30T18:17:29+00:00April 30th, 2013|Cancer, Mesenchymal Stem Cells, News, Stem Cell Research|

Killing of the iPS Field?

Zhao et al. Nature. Embryonic stem cells are associated with numerous ethical dilemmas. The creation of equivalents of ES cells through retrodifferentiation led to a new area of research that does not require destruction of life. Specifically, it was discovered that any adult cell can be transfected with several genes, which results in the cell [...]

2011-05-13T19:31:38+00:00May 13th, 2011|News, Stem Cell Research|

World’s First Chemical Guided Missile Could Be the Answer to Wiping out Cancer

A research team at Deakin University has made a discovery that could have huge implications on the treatment and survival rates of cancer victims. The researchers, along with scientists in India and Australia have created the world’s first RNA aptamer, a chemical antibody that targets cancer stem cell marker epithelial cell adhesion molecule (EpCAM). This [...]

2011-02-17T20:24:44+00:00February 17th, 2011|News, Stem Cell Research|

Pluripotent stem cell-derived natural killer cells for cancer therapy.

Knorr et al. Transl Res. 2010 Sep;156(3):147-154. Epub Immune therapy of cancer is an exciting prospect given the possibility of treating cancer without the side effects associated with conventional treatments such as chemotherapy or radiotherapy. Additionally, the use of the immune system to target tumors offers the possibility of eradicating micrometastasis, which often cannot be [...]

2010-08-01T16:46:36+00:00August 1st, 2010|Cancer, News, Stem Cell Research|

Identification of Peptides Which Show Potential To Generate Cancer Stem Cell Specific Immune Responses

The use of the immune system to target cancer has been a therapeutic goal for over a century. The advantage of immunotherapy is the possibility of targeting cancer throughout the body in a non-toxic manner, thus allowing destruction of metastasis, and induction of immunological memory to protect from relapse. Unfortunately with exception of the recent [...]

2010-05-17T17:13:31+00:00May 17th, 2010|News, Stem Cell Research|